Cyklokapron (Tranexamic Acid) - Summary

CYKLOKAPRON SUMMARY

Cyklokapron^®
tranexamic acid tablets and tranexamic acid injection

Each tablet contains 500 mg of tranexamic acid.Each mL of the sterile solution for intravenous injection contains 100 mg tranexamic acid and Water for Injection to 1 mL.

CYKLOKAPRON Tablets and Injection are indicated in patients with hemophilia for short term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.

See all Cyklokapron indications & dosage >>

CYKLOKAPRON NEWS HIGHLIGHTS

Published Studies Related to Cyklokapron (Tranexamic Acid)

Prospective, randomized, controlled trial of tranexamic acid in patients who undergo head and neck procedures. [2008.06]

Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study. [2008.04]

Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. [2008.02]

Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. [2007.07]

Preventive treatment of intrauterine device-induced menstrual blood loss with tranexamic acid in Chinese women. [2007]

more >>

Clinical Trials Related to Cyklokapron (Tranexamic Acid)

A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac Surgery [Completed]

Safety of Tranexamic Acid in Reducing Bleeding in Adults Undergoing Spinal Surgery [Completed]

Tranexamic Acid in HIp Fracture Surgery (THIF Study) [Terminated]

Tranexamic Acid in Urologic Surgery [Recruiting]

Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery? [Completed]

more >>